Method for determining the risk of preeclampsia using PIGF-2 and PIGF-3 markers

Details for Australian Patent Application No. 2009316392 (hide)

Owner PerkinElmer Health Sciences, Inc. NTD Laboratories, Inc. Wallac OY

Inventors Ahola, Tarja; Frang, Heini; Korpimaki, Teemu; Hurskainen, Pertti; Bobrow, Mark N.; Carmichael, Jonathan B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009316392

PCT Pub. Number WO2010/059952

Priority 61/116,366 20.11.08 US

Filing date 20 November 2009

Wipo publication date 27 May 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059952 Priority application(s): WO2010/059952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316409-Use of anti-VEGF antibody in combination with chemotherapy for treating breast cancer

2009316387-Methods and compositions for diagnosis and prognosis of renal injury and renal failure